A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy

NCT02193672 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: [18F] Fluciclatide
PROCEDURE: PET/CT Scan
BEHAVIORAL: Phone Calls

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]